Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Advanced-stage Hodgkin Lymphoma (German Hodgkin Study Group protocol).
Testicular germ cell tumors, malignant ovarian germ cell tumors, and extragonadal germ cell tumors.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Relapsed/refractory B-cell Acute Lymphoblastic Leukemia (ALL) or CD33-positive Acute Myeloid Leukemia (AML).
Approved for use in oncology care according to FDA-approved indications.
Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma, Renal Cell Carcinoma, Gastric Cancer, and Ovarian Cancer.